Results     16-May-24
Announcements
Biocon consolidated net profit declines 56.74% in the March 2024 quarter
Sales rise 3.79% to Rs 3917.10 crore
Net profit of Biocon declined 56.74% to Rs 135.50 crore in the quarter ended March 2024 as against Rs 313.20 crore during the previous quarter ended March 2023. Sales rose 3.79% to Rs 3917.10 crore in the quarter ended March 2024 as against Rs 3773.90 crore during the previous quarter ended March 2023.

For the full year,net profit rose 120.99% to Rs 1022.50 crore in the year ended March 2024 as against Rs 462.70 crore during the previous year ended March 2023. Sales rose 32.05% to Rs 14755.70 crore in the year ended March 2024 as against Rs 11174.20 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales3917.103773.90 4 14755.7011174.20 32
OPM %23.3125.36 -21.7820.98 -
PBDT734.80863.30 -15 3105.602301.60 35
PBT327.80499.60 -34 1536.801188.50 29
NP135.50313.20 -57 1022.50462.70 121

Previous News
  Biocon Ltd spurts 1.07%, gains for fifth straight session
 ( Hot Pursuit - 03-Jul-25   13:00 )
  Nifty above 25,550 mark; oil & gas shares jump
 ( Market Commentary - Mid-Session 03-Jul-25   10:39 )
  Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars
 ( Hot Pursuit - 03-Jul-25   09:50 )
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
 ( Corporate News - 03-Jul-25   09:12 )
  Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
 ( Hot Pursuit - 27-Jun-25   12:18 )
  Biocon raises Rs 4,500 crore via QIP
 ( Hot Pursuit - 21-Jun-25   09:13 )
  Restaurant Brands Asia Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Jun-25   12:00 )
  Biocon get facilities rated
 ( Corporate News - 18-Jun-25   09:41 )
  Indices drift lower in early trade; breadth positive
 ( Market Commentary - Mid-Session 17-Jun-25   09:37 )
  Biocon Ltd soars 3.52%, Gains for third straight session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Biocon gets CDSCO approval for Liraglutide drug substance
 ( Hot Pursuit - 03-Jun-25   08:23 )
Other Stories
  Vasudhagama Enterprises consolidated net profit declines 86.67% in the March 2025 quarter
  30-Jun-25   07:28
  Mahesh Developers reports standalone net profit of Rs 0.05 crore in the March 2025 quarter
  28-Jun-25   07:32
  Maxgrow India reports standalone net loss of Rs 4.52 crore in the March 2025 quarter
  28-Jun-25   07:32
  Rose Merc. reports consolidated net loss of Rs 0.69 crore in the March 2025 quarter
  28-Jun-25   07:32
  NMS Global reports consolidated net profit of Rs 0.21 crore in the March 2025 quarter
  28-Jun-25   07:31
  GCCL Construction & Realities standalone net profit declines 46.67% in the March 2025 quarter
  27-Jun-25   07:34
  Konkan Railway Corporation standalone net profit declines 69.17% in the March 2025 quarter
  27-Jun-25   07:34
  Jorabat Shillong Expressway reports standalone net loss of Rs 10.15 crore in the March 2025 quarter
  27-Jun-25   07:34
  Rare Asset Reconstruction reports standalone net loss of Rs 2.46 crore in the March 2025 quarter
  27-Jun-25   07:34
  Prestige Projects Pvt standalone net profit declines 99.73% in the March 2025 quarter
  27-Jun-25   07:34
Back Top